# Bright Minds Biosciences Inc.: Form 20-F for the period ended Sep 30, 2024

- Company: [Bright Minds Biosciences Inc.](/companies/drug.md) (CIK 1827401)
- Form: 20-F
- Filed: 2024-12-31
- Accepted by EDGAR: Dec 30, 2024, 19:35 ET
- Period: 2024-09-30
- Accession: 0001062993-24-021301
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1827401/000106299324021301/form20f.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1827401/000106299324021301/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2024-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Income tax | 12 months, 2023-10-01 to 2024-09-30 | CAD 0 | ifrs-full:IncomeTaxExpenseContinuingOperations |
| Net income | 12 months, 2023-10-01 to 2024-09-30 | −CAD 2.8m | ifrs-full:ProfitLoss |
| Diluted EPS | 12 months, 2023-10-01 to 2024-09-30 | −CAD 0.65 | ifrs-full:DilutedEarningsLossPerShare |
| Basic EPS | 12 months, 2023-10-01 to 2024-09-30 | −CAD 0.65 | ifrs-full:BasicEarningsLossPerShare |
| Operating cash flow | 12 months, 2023-10-01 to 2024-09-30 | −CAD 1.9m | ifrs-full:CashFlowsFromUsedInOperatingActivities |
| Cash and equivalents | at 2024-09-30 | CAD 5.7m | ifrs-full:CashAndCashEquivalents |
| Current assets | at 2024-09-30 | CAD 6.0m | ifrs-full:CurrentAssets |
| Total assets | at 2024-09-30 | CAD 6.1m | ifrs-full:Assets |
| Current liabilities | at 2024-09-30 | CAD 528.7k | ifrs-full:CurrentLiabilities |
| Total liabilities | at 2024-09-30 | CAD 568.3k | ifrs-full:Liabilities |
| Shareholders' equity | at 2024-09-30 | CAD 5.5m | ifrs-full:Equity |
| Shares outstanding | at 2024-09-30 | 4,524,087 shares | dei:EntityCommonStockSharesOutstanding |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1827401/000106299324021301/form20f.htm

Filed Dec 31, 2024.
Source: SEC EDGAR, the filing index for accession 0001062993-24-021301. Last ingested by Listed: Nov 2, 2026, 18:24 ET. No prices; not investment advice.